🔴 Edesa Biotech is trading 7% down in pre-market

Edesa Biotech is trading at $3.73, down 6.98% in pre-market; no company-specific catalyst has been confirmed.

• The shares are below the September 25 close of $4.01.
• No new company-specific announcement for September 28 was identified. The company’s news page lists a public-offering pricing announcement dated September 23.
• In the supplied pre-market context, the S&P 500 is down 0.54% and the Nasdaq Composite is down 1.02%; no volume information was reported.